Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia.
Saved in:
| Title: | Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia. |
|---|---|
| Authors: | Bonifazi A; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD., Ellenberger M; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD., Farino ZJ; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA., Aslanoglou D; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA., Rais R; Department of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, Baltimore, MD., Pereira S; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Physiology, University of Toronto, Toronto, Ontario, Canada., Mantilla-Rivas JO; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA., Boateng CA; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD., Eshleman AJ; Research Service, Veterans Affairs Portland Health Care System, Portland, OR.; Departments of Behavioral Neuroscience and Psychiatry, Oregon Health & Science University, Portland, OR., Janowsky A; Research Service, Veterans Affairs Portland Health Care System, Portland, OR.; Departments of Behavioral Neuroscience and Psychiatry, Oregon Health & Science University, Portland, OR.; Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, OR., Hahn MK; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Banting & Best Diabetes Centre, Toronto, Ontario, Canada., Schwartz GJ; The Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, NY.; Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY., Slusher BS; Department of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, Baltimore, MD., Newman AH; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD., Freyberg Z; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.; Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA. |
| Source: | Diabetes [Diabetes] 2024 Sep 01; Vol. 73 (9), pp. 1411-1425. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1939-327X |
|---|---|
| DOI: | 10.2337/db24-0175 |
